Artia Global Partners’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.98M | Hold |
316,700
| – | – | 0.72% | 16 |
|
|
2025
Q1 | $1.72M | Buy |
316,700
+100,000
| +46% | +$542K | 0.43% | 23 |
|
|
2024
Q4 | $1.61M | Buy |
216,700
+60,400
| +39% | +$450K | 0.58% | 24 |
|
|
2024
Q3 | $1.25M | Buy |
156,300
+54,800
| +54% | +$438K | 0.34% | 27 |
|
|
2024
Q2 | $883K | Buy |
101,500
+50,000
| +97% | +$435K | 0.17% | 36 |
|
|
2024
Q1 | $1.06M | Buy |
51,500
+1,500
| +3% | +$31K | 0.21% | 37 |
|
|
2023
Q4 | $1.16M | Buy |
+50,000
| New | +$1.16M | 0.34% | 20 |
|